Sponsor Pipeline

Zhejiang Anglikang Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07509684 A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors Advanced Solid Tumors Not Yet Recruiting
Get alerts when Zhejiang Anglikang Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free